Technical Analysis for OPNT - Opiant Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 13.37 -9.05% -1.33
OPNT closed down 9.05 percent on Monday, March 18, 2019, on 2.7 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical OPNT trend table...

Date Alert Name Type % Chg
Mar 18 MACD Bearish Centerline Cross Bearish 0.00%
Mar 18 Stochastic Reached Oversold Weakness 0.00%
Mar 18 Below Lower BB Weakness 0.00%
Mar 18 Lower Bollinger Band Touch Weakness 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 50 DMA Resistance Bearish -9.05%
Mar 15 Inside Day Range Contraction -9.05%
Mar 14 Fell Below 20 DMA Bearish -7.27%
Mar 14 Fell Below 50 DMA Bearish -7.27%
Mar 14 MACD Bearish Signal Line Cross Bearish -7.27%

Older signals for OPNT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Opiant Pharmaceuticals, Inc., formerly Lightlake Therapeutics, Inc., is a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive and eating disorders. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug Administration (FDA). The Company's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED), a treatment for Bulimia Nervosa (BN), a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The Company also is focused on other treatment opportunities.
Medicine Chemistry Pharmaceutical Organic Chemistry Company's Pipeline Heroin Addiction Bulimia Nervosa Naloxone United States Food And Drug Administration
Is OPNT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.55
52 Week Low 12.02
Average Volume 20,506
200-Day Moving Average 16.1198
50-Day Moving Average 14.8049
20-Day Moving Average 15.0062
10-Day Moving Average 15.1229
Average True Range 0.8234
ADX 19.48
+DI 18.226
-DI 24.3884
Chandelier Exit (Long, 3 ATRs ) 14.2798
Chandelier Exit (Short, 3 ATRs ) 15.8402
Upper Bollinger Band 16.2368
Lower Bollinger Band 13.7756
Percent B (%b) -0.16
BandWidth 16.401221
MACD Line -0.108
MACD Signal Line 0.0606
MACD Histogram -0.1686
Fundamentals Value
Market Cap 27.23 Million
Num Shares 2.04 Million
EPS 2.94
Price-to-Earnings (P/E) Ratio 4.55
Price-to-Sales 4.44
Price-to-Book 18.77
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.98
Resistance 3 (R3) 15.16 14.80 14.71
Resistance 2 (R2) 14.80 14.39 14.71 14.62
Resistance 1 (R1) 14.08 14.14 13.91 13.91 14.53
Pivot Point 13.73 13.73 13.64 13.64 13.73
Support 1 (S1) 13.01 13.32 12.83 12.83 12.21
Support 2 (S2) 12.66 13.07 12.57 12.12
Support 3 (S3) 11.94 12.66 12.03
Support 4 (S4) 11.76